申请人:Promidis S.r.l.
公开号:EP3865489A1
公开(公告)日:2021-08-18
The present invention relates to compounds that are inhibitors of hepatitis B virus (HBV). Compounds of this invention are useful alone or in combination with other agents for treating, ameliorating, preventing or curing HBV infection and related conditions. The present invention also relates to pharmaceutical compositions containing said compounds.
本发明涉及作为乙型肝炎病毒(HBV)抑制剂的化合物。本发明的化合物可单独使用或与其他药物联合使用,用于治疗、改善、预防或治愈 HBV 感染及相关病症。本发明还涉及含有上述化合物的药物组合物。